Low-dose rivaroxaban plus aspirin for elderly patients with symptomatic peripheral artery disease: is it worth the bleeding risk?

Juqian Zhang, S R Vallabhaneni, Gregory Y H Lip*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

4 Citations (Scopus)
Original languageEnglish
Article numberehab602
JournalEuropean Heart Journal
Volume42
Issue number39
Pages (from-to)4049-4052
Number of pages4
ISSN0195-668X
DOIs
Publication statusPublished - 14 Oct 2021

Cite this